Antinuclear antibodies;Anticuerpos antinucleares

Reumatologia Clinica

Volumn 6, Issue 4, 2010, Pages 224-230

  Cabiedes, Javier ^a   Núñez Álvarez, Carlos A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Antinuclear antibodies; Autoimmune diseases; Indirect immunofluorescence

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; DOUBLE STRANDED DNA; IMMUNOGLOBULIN;

ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; SCREENING TEST; WESTERN BLOTTING;

EID: 77953698657     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2009.10.004     Document Type: Article

References (27)

1. Hargraves M.M., Richmond H., and Morton R. Presentation of two bone marrow elements; "tart" cell and L.E cell. Proc Mayo Clin 23 (1948) 25-28
2. Holman H., and Deicher H.R. The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus. J Clin Invest 38 (1959) 2059-2072
3. Coons A.H., and Kaplan M.H. Localization of antigen in tissue cells II: Improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med 91 (1950) 1-13
4. Tan E.M., and Kunkel H.G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 96 (1966) 464-471
5. Tan E.M., Christian C., Holman H.R., Homma M., Kunkel H.G., Reichlin M., et al. Anti-tissue antibodies in rheumatic disease. Standardization and nomenclature. Arthritis Rheu 20 (1977) 1419-1420
6. Tan E.M. Autoantibodies to nuclear antigens (ANA): Their Immunobiology and Medicine, in: advances in immunology. Pub Academic Press Inc 33 (1982) 167-240
7. Conrad K., SchöBler W., Hiepe F., and Fritzler M. Autoantibodies in systemic autoimmune disease. A diagnostic Reference. Autoantigens, autoantibodies, autoimmunity. Edi. PABST 2 (2002) 21
8. Tan E.M., Feltkamp T.E.W., Smolen J.S., Butcher B., Dawkins R., Fritzler M.J., et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheu 40 (1997) 1601-1611
9. Rosas I., Gómez E.I., Núñez Álvarez C.A., Huerta M.T., Alvarado A., and Cabiedes J. Prevalencia de anticuerpos antinucleares (ANA) en donadores sanos del Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Rev. Mex Reumatol 20 (2005) 72
10. Shoenfeld Y., Gershwin M.E., and Meroni P.L. Autoantibodies. Elsevier 2 (2007) 3-6
11. Damoiseaux J.G.M.C., and Cohen Tervaert J.W. From ANA to ENA: How to proceed?. Autoimmunty Rev 5 (2006) 10-17
12. Shoenfeld Y., Gershwin M.E., and Meroni P.L. Autoantibodies. Elsevier 2 (2007) 37-46
13. Torrico R. Prevalencia de autoanticuerpos en pacientes con diagnóstico de Esclerodermia. Tesina de Especialidad en Bioquímica Clínica (2009) UNAM-INCMNSZ
14. Pagola Santander L., Núñez Álvarez C.A., Martínez Castillo A., Hernández-Ramírez D.F., Cabral A.R., García Hernández J.L., et al. Caracterización inmunoquímica de los patrones de inmunofluorescencia (IFI) moteado fino y moteado grueso en pacientes con enfermedades autoinmunes. Reumatol Clin 5 (2009) 55
15. Bradwell AR, Hugues RG. Atlas of HEp-2 patterns. Third Ed., The Binding Site, 2007.
16. Mimori T. Atlas of antinuclear antibodies. Medical & Biological Laboratories CO, LTD. RhiGene Inc. 2nd Ed. 1999.
17. Sheldon J. Laboratory testing in autoimmune rheumatic diseases. Best Practice & and Research Clinical Rheumatology 18 (2004) 249-269
18. Keren D.F. Antinuclear antibody testing. Clin Lab Med 22 (2002) 447-474
19. Tozzoli R., Bizarro N., and Tonutti E. Guidelines for the laboratory use of autoantibody test in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117 (2002) 316-324
20. Martínez Bezies V. Asociación ente las características de las metafases con la actividad de los anticuerpos anticromatina en pacientes con enfermedades autoinmunes. Tesina de Especialidad en Bioquímica Clínica (2007) UNAM-INCMNSZ
21. Hugues RG, Surmacz MJ, Karim AR, Bradwell AR. Atlas of autoantibody patterns on Tissues. Third Ed. The Binding Site 2008; p. 32-34.
22. Marin G.G., Cardiel M.H., Cornejo H., and Viveros M.E. Prevalencia de ANA en tres grupos de población mestizo-mexicana sana: donadores de sangre, personal médico-sanitario y familiares de pacientes con enfermedad autoinmune. Reumatol Clin 4 (2008) 55
23. Alvarado Hernández A, Cachafeiro Vilar A, Pascual Ramos V, Gabilondo Navarro F, Núñez Alvarez CA, Cabral AR, et al. Detección de anti-DNA de cadena doble por cuatro. Validación del ELISA caotrópico. Enviado
24. Kavanaugh A., Tomar R., Reveille J., Solomon D.H., and Homburger H.A. Guidelines for clinical use of the antionuclear antibody test and test for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 124 (2000) 71-81
25. Solomon D.H., Kavanaugh A., and Schur P.H. Evidence-based guidelines for the use of immunologic test: antinuclear antibody testing. Arthritis Rheu 47 (2002) 434-444
26. Tampoia M., Fontana A., Di Serio F., Maggiolini P., and Pansini N. Application of a diagnostic algorithm in autoantibody testing: assessment of clinical effectiveness and economic efficiency. Clinic Chimica Acta (2003) 181-183
27. Tampoia M., Brescia V., Fontana A., Zucano A., Morrone L.F., and Pansini N. Application of a combined protocol for rational request and utilization of antibody assays improve clinical diagnostic efficacy in autoimmune rheumatic disease. Arch Pathol Lab Med 131 (2007) 112-116